Can aspirin ease COPD symptoms? new study seeks the right dose

NCT ID NCT05265299

First seen Mar 21, 2026 · Last updated Apr 28, 2026 · Updated 3 times

Summary

This study looks at whether aspirin can reduce inflammation and improve breathing in people with COPD, a serious lung disease. Researchers will test different daily doses of aspirin in 48 former smokers to find the dose that best blocks overactive blood cells linked to inflammation. The goal is to design a larger trial that could lead to a new, simple treatment for COPD symptoms.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PULMONARY DISEASE, CHRONIC OBSTRUCTIVE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Johns Hopkins Bayview Medical Center

    RECRUITING

    Baltimore, Maryland, 21224, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.